Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1138 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Daiichi Sankyo introduces AD drug in Japan

Memary, an N-methyl-D-aspartate (NMDA) receptor antagonist, is the generic version of Memantine Hydrochloride, which was licensed from Merz Pharmaceuticals. Daiichi Sankyo has obtained the Japanese approval to manufacture

FDA approves Watson generic contraceptive pill

Watson‘s Levonorgestrel and Ethinyl Estradiol Tablets, USP, 0.09mg/0.02mg are the generic version of Lybrel Tablets of Pfizer. Lybrel is indicated for the prevention of pregnancy in women who

Lonza to expand Singapore manufacturing plant

The expansion will add 1858m² of space and associated equipment and support cell line construction, upstream and downstream process development, and a range of analytical services. The expanded

FDA allows Actavis to market generic insomnia drug

The company has already started distribution of the Zolpidem Tartrate Extended-Release Tablets, the generic equivalent of Ambien CR. Sanofi-aventis’ Ambien CR is indicated for the treatment of insomnia